Evaluation of five chromogenic agar media and the ROSCO Rapid CARB Screen kit for the
|
|
- Robert Crawford
- 6 years ago
- Views:
Transcription
1 JCM Accepts, published online ahead of print on 29 October 2014 J. Clin. Microbiol. doi: /jcm Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 Evaluation of five chromogenic agar media and the ROSCO Rapid CARB Screen kit for the detection and confirmation of carbapenemase production in Gram-negative bacilli Patricia J. Simner, a,b # Matthew W. Gilmour, a,b Pat DeGagne, a Kim Nichol, a and James A. Karlowsky a,b Diagnostic Services Manitoba, Winnipeg, Manitoba, Canada a ; University of Manitoba, Department of Medical Microbiology and Infectious Diseases, Winnipeg, Manitoba, Canada b 9 10 Running Title: Detection of carbapenemase-producing Gram-negatives # Address correspondence to Patricia J. Simner, psimner@dsmanitoba.ca 1
2 13 Abstract: An efficient workflow to screen for and confirm carbapenemase-producing Gram-negative bacilli was developed by evaluating five chromogenic screening agar media and two confirmatory assays, the Rapid CARB Screen(Rosco Diagnostica A/S, Tasstrup, Denmark) test and the modified Hodge test. A panel of 150 isolates was used, including 49 carbapenemaseproducing isolates representing a variety of β-lactamase enzyme classes. Evaluation of analytical performance, assay cost and turnaround time indicated that the preferred workflow (screening test followed by confirmatory testing) was chromid CARBA agar media (biomémieux, Marcy-l Etoile, France) followed by the Rapid CARB Screen test, yielding a combined sensitivity of 89.8% and a specificity of 100%. As an optional component of the workflow, determination of carbapenemase gene class via molecular means could be performed subsequent to confirmatory testing. 25 2
3 26 Introduction: The worldwide dissemination of carbapenemase-producing Gram-negative bacilli (CPGNB) is a significant clinical and public health concern (10, 14). Rapid detection of these antibiotic resistant pathogens by the clinical microbiology laboratory is of utmost importance to control nosocomial spread and initiate appropriate antimicrobial therapy. Chromogenic media containing a carbapenem are convenient tools for screening and rapid detection of carbapenem resistant Gram-negative bacilli (GNB). However, growth on a chromogenic media simply signifies carbapenem resistance (e.g., an AmpC producer with porin loss may grow) and does not confirm the production of a carbapenemase. Recently, a novel rapid chromogenic test based on the hydrolysis of imipenem, the CarbaNP test, and a commercial version of the CarbaNP test, the Rapid CARB screen (RCS), have been described (3, 5, 11-13, 16). The purpose of the current study was to evaluate screening and confirmation methods, that when paired, would provide a streamlined workflow to detect CPGNB in the clinical microbiology laboratory. Firstly, five different chromogenic media were evaluated to select a sensitive media type to screen for CPGNB. Secondly, the RCS test (Rosco Diagnostica A/S, Tasstrup, Denmark) was evaluated to confirm carbapenemase production through a method comparison to the current gold standard modified Hodge (MH) test (1). A combined workflow approach was designed to achieve the maximum sensitivity and specificity for the detection of CPGNB, with consideration for cost and turnaround time of testing. Lastly, upon finding a CPGNB, it may be of value in some circumstances to determine the carbapenemase gene class, and therefore an established multiplex PCR was also incorporated as an optional endpoint to this workflow. 3
4 47 Materials and Methods: Bacterial Isolates. A total of 150 isolates were tested including an assortment of 49 isolates of GNB harboring a diverse set of carbapenemase enzyme classes and 101 carbapenemase negative isolates. The 49 carbapenemase producers, a combination of clinical and ATCC strains, were previously molecularly characterized for β-lactamase genes and included 16 KPC producers (bla KPC-2 [n=9], -3 [n=5], -11 [n=1],-12 [n=1] ; Citrobacter freundii, n=2; Citrobacter koseri, n=1; Enterobacter cloacae, n=1; Escherichia coli, n=4; Klebsiella oxytoca, n=1; Klebsiella pneumoniae, n=5; Pseudomonas aeruginosa, n=1; Serratia marcenscens, n=1), 12 VIM producers (bla VIM-1 [n=6],-2 [n=3],-4 [n=2],-5 [n=1] ; C. freundii, n=2; C. koseri, n=1; Enterobacter aerogenes, n=1; E. cloacae, n=1; K. oxytoca, n=1; Proteus mirabilis, n=1; Providencia stuartii, n=1; P. aeruginosa, n=5 ), 4 IMP producers (bla IMP-1,-26 ; E. coli, n=1; K. pneumoniae, n=2; P. aeruginosa, n=1), 9 NDM producers (bla NDM-1 [n=6], -4 [n=1], -5 [n=1], -7 [n=1] ; Acinetobacter baumanii, n=1; E. coli, n=4; K. oxytoca, n=1; K. pneumoniae, n=1; P. mirabilis, n=1; Providencia rettgerii, n=1), 8 OXA producers (bla OXA-24 [n=1],-48 [n=7] ; A. baumanii, n=1; C. koseri, n=1, E. cloacae, n=1; K. pneumoniae, n=3; Morganella morganii, n=1, S. marcescens, n=1) and one SME producer (S. marcescens, n=1). Of note, one E. cloacae isolate possessed both VIM-4 and OXA-48. The 101 carbapenemase-negative isolates included extended-spectrum β-lactamse (ESBL) and AmpC producers (previously molecularly characterized) with and without porin mutations, clinical isolates with elevated carbapenem minimum inhibitory concentrations (and negative for carbapenemases by PCR) and carbapenem susceptible isolates. The isolates were blinded and 75 isolates were distributed to each of the two clinical microbiology laboratory testing sites (Health Sciences Centre and St. Boniface Hospital, Winnipeg, Canada). 4
5 Chromogenic Media to Screen for CPGNB: The first part of this study involved evaluating five different chromogenic media types to screen for CPGNB. The five chromogenic media evaluated were: 1) Oxoid Brilliance ESBL (Besington, Hants, UK), 2) Oxoid Brilliance CRE, 3) biomérieux chromid TM CARBA (Marcy-l Etoile,France), 4) CHROMAgar Colorex C3Gr (Paris, France) and 5) CHROMagar Colorex KPC. The Brilliance ESBL and Colorex C3Gr media are designed to detect ESBLs, and in this study were evaluated both with and without an ertapenem disk (10 μg) to select for carbapenem resistant isolates. Inoculums for each of the chromogenic media types and a nonselective blood agar (BA) plate were 10 μl (~10 6 CFU/mL) of a 0.5 McFarland standard prepared in sterile saline (0.85%). Brilliance ESBL, Brilliance CRE and chromid CARBA were streaked using the Isoplater (Vista Technology Inc, Edmonton, Alberta, Canada) to mimic standard laboratory practice. The Colorex media C3Gr and Colorex KPC were evaluated as a biplate so the media were streaked manually. Ertapenem disks were placed between the 2 nd and 3 rd quadrant of the Brilliance ESBL and Colorex C3Gr media following streaking of the plate. The plates were incubated for 24 hours at 37 o C and the presence/absence and color of growth were interpreted according to the package inserts. Any isolate on the ESBL chromogenic media with an ertapenem zone of inhibition of 27 mm were considered putative carbapenemase producers and would be considered for further evaluation using a confirmatory method. The use of the 27mm cut-off was established in a previous study using an ertapenem disk (10 μg) to screen for carbapenem resistant GNB on MacConkey media (6). 5
6 Phenotypic Confirmatory Asssays: In the second part of the study, a method comparison between the MH test and the RCS, was performed on all study isolates, using growth from the BA plate inoculated concurrent with the chromogenic media. The BA plate was added to perform the confirmatory tests the following day since the RCS cannot be performed off the chromogenic media as the color of the colonies interferes with the interpretation of the test. The MH test using meropenem disks (10 μg) was performed and interpreted according to CLSI methodology (1). The RCS is a, commercially available, rapid chromogenic test for the detection of carbapenemases based on the hydrolysis of the imipenem in the presence of an inidicator [phenol red, (11)]. All the components of the assay are present within tablets called diatabs. Two sets of diatabs are contained in the kit, one set contains imipenem and the second set does not contain imipenem. The diatabs are dissolved in saline and the lysate of the organism is added to a tube with a dissolved diatab with imipenem and a tube with a dissolved diatab without imipenem (negative control tube; should remain red in color). Initially, the RCS was performed as previously described (5). K. pneumoniae ATCC BAA1706 and K. pneumoniae ATCC BAA1705 were the positive and negative controls, respectively. Any color change from red to yellow in the 1.5 ml test tube containing imipenem was considered a positive reaction for the RCS. Uninterpretable results were isolates that would give a slight positive reaction (peach color) in both tubes with and without imipenem As there were many uninterpretable results initially with the previously described RCS protocol, the RCS protocol was troubleshot by determining the appropriate inoculum by testing one to three calibrated loops of organism and determining the optimal tube to perform the assay by testing 1.5 ml test tubes, cryovials, and round-bottomed 15 ml tubes. Thus, the 6
7 modified RCS was performed upon repeat on all isolates to only include one 10 µl calibrated loopful of organism (reduced from two) and a round-bottomed 15 ml tube (instead of a conical 1.5 ml tube). As there was variability in the degree of color change for positives with the modified RCS, positives were considered any color change from the negative control tubes (tubes without imipenem). Isolates that were orange by the modified RSC protocol in this study were repeated using both the RCS and the CarbaNP, as previsouly described, to assess ease of interpretation of the intermediate results (3, 11, 13) Conventional Multiplex PCR: Lastly, a conventional multiplex PCR for bla KPC, bla NDM, bla VIM, bla IMP and bla OXA-48/181 was performed on all isolates as previously described (8). In addition, a bla SME PCR was performed on one isolate to confirm SME production (7) Determination of an Optimal Workflow for the Screening and Confirmation of CPGNB: The results of the screening and confirmatory assays (performed on all test isolates) was analyzed to develop the optimal workflow (i.e., test choice) for the detection and confirmation of CPGNB. By combining the individual data from the chromogenic media and the confirmatory assays we were able to determine the sensitivity and specificities of the combined assays. In addition, the cost and time to perform the different combination of assays were evaluated and considered for feasibility and full optimization of the workflow within a clinical microbiology laboratory. 130 Results: Chromogenic media for CPGNB: The first part of this study involved evaluating five different chromogenic media types to screen for CPGNB, including two media targeting ESBLs 7
8 supplemented with and without an ertapenem disk (Table 1). Of the five different chromogenic media evaluated to detect CPGNB (Table 1), Colorex C3Gr without the ertapenem disk had the highest sensitivity, 95.9%. However, the two ESBL media types, Colorex C3Gr and Brilliance ESBL, without the use of the ertapenem disk both had a specificity of 38.6% for CPGNB. The addition of the ertapenem disk to Colorex C3Gr and Brilliance ESBL resulted in an increased specificity of 62.4% and 94.1%, however, it resulted in a loss of sensitivity of 89.8 and 42.9%, respectfully Among the three chromogenic media designed for detection of CPGNB, chromid CARBA demonstrated the highest sensitivity and specificity, followed by Colorex KPC and Brilliance CRE. The chromid CARBA media failed to identify 5 CPGNB (3 isolates with OXA-48, 1 isolate with VIM-1 and 1 isolate with VIM-5). The Colorex KPC and Brilliance CRE media failed to support the growth of these same five isolates; Colorex KPC additionally did not detect one of each of NDM-1 producer, KPC-2 producer and SME producer; Brilliance CRE additionally did not detect one of each of VIM-2, 1 IMP-26, 1 SME and one OXA-48/VIM-4 producers. All three media designed for detection of CPGNB performed poorly for the detection of OXA-48 producers, detecting at the most five of the 8 (63.5%) OXA-48 producers Phenotypic Confirmatory Assays: In the second part of the study, a method comparison between the MH test and the RCS was performed on all isolates. On the first attempt with the previously described RCS protocol, 29 (28.7%) of the carbapenemase-negative isolates gave uninterpretable results (peach color in both tubes with and without imipenem (e.g., Figure 1. C2a & C2b). In addition, 4 of the carpabenemase producers were interpreted as negative (3 8
9 OXA-48 producers and 1 SME producer). Based off the initial results, the RCS protocol was troubleshot and modified upon repeat to only include one 10 µl calibrated loopful of organism (reduced from two) and a round-bottomed 15 ml tube (instead of a conical 1.5 ml test tube) to allow the diatab to dissolve completely (Figure 1) It was noted that different enzyme classes performed differently with the RCS. KPC producers would turn the bacterial suspension a characteristic bright yellow color (positive test) immediately or within minutes of inoculating the test, all VIM and IMP producers would be positive at 30 minutes, whereas NDM and OXA producers and other CPGNB with relatively low carbapenem MICs would turn color more slowly and would yield an intermediate orange hue toward the end of incubation. Three of the carbapenemase positive isolates displayed intermediate positive results (orange hue) which included 3 of the 4 called negative by unmodified RCS (2 OXA-48 producers and one SME producer). Those isolates that yielded an orange color towards the end of incubation in this study were repeated using both the RCS and the CarbaNP tests, to determine which assay was easier to interpret for intermediate results [Figure 2, (3, 11, 13)]. Although both the RCS and the CarbaNP tests did yield the same intermediate orange color, it was found that the CarbaNP was easier to interpret the intermediate positives. As there was variability in the degree of color change for positives with the modified RCS, positives were considered any color change from the negative control tubes (tubes without imipenem). Using this as a marker of positivity as opposed to a strict yellow color change, sensitivity reached 98.0% and specificity was 100%. The RCS failed to identify one OXA-48 producing K. pneumoniae. 9
10 Conventional Multiplex PCR: The multiplex PCR for determination of carbapenemase gene class was verified with a sensitivity and specificity of 95.9% and 100%, respectively. The PCR failed to identify one OXA-24 producer and one SME producer. It was expected that bla OXA-24 was not detected by the multiplex PCR as this assay targetsbla OXA-48/181 specifically. Similarly, bla SME is not one of the targets included in the multiplex PCR. However, a PCR specific to SME was performed on the isolate and was found to be positive. Considering only the genes targeted by the multiplex PCR, the sensitivity and specificity achieved was 100% Determination of an Optimal Workflow for the Screening and Confirmation of CPGNB: The results of the screening and confirmatory assays (performed on all test isolates) were analyzed to develop the optimal workflow for the detection and confirmation of CPGNB. The best combination of tests in terms of analytical performance and assay cost and turnaround time was the use of chromid CARBA media for screening followed by the RCS test or multiplex PCR for confirmation as a CPGNB (89.8%, Table 1). The Colorex C3Gr media paired with the RCS did have the highest combined sensitivity (95.9%; partly due to the improved sensitivity to detect OXA producing strains, but not reaching 100% sensitivity in this enzyme class), however the low specificity of ESBL chromogenic screening media for CPGNB would greatly impact the overall cost of testing if routinely implemented. The large proportion of false positive CPGNB on Colorex C3Gr media that would be encountered under routine conditions (where ESBLs and organisms with reduced carbapenem susceptibility dominate in incidence over true CPGNB) would make it cost and time prohibitive. 10
11 Discussion: The development of a screening and confirmatory method for the detection and confirmation of CPGNB is complicated by the scope of genera and enzyme classes encompassed in this broad group of antimicrobial resistant organisms. This study aimed to provide an optimal workflow for the detection of CPGNB to be implemented within the clinical microbiology laboratory. As such, a comprehensive evaluation of multiple chromogenic media and confirmatory methods were evaluated for their analytical performance and assay cost and turnaround time. Overall, we found that chromid CARBA media paired with the modified RCS protocol was the optimal approach (Figure 3), yielding a combined sensitivity of 89.8% and a specificity of 100%. The multiplex PCR for carbapenemase genes provided an equal analytical performance when paired with the chromid CARBA media, but of note, our laboratory system selected the RCS test as the confirmatory component for cost and time-to-reporting considerations. The RCS was $6.38 less per test and was anticipated to be completed at minimum 3 hours prior to the PCR result. However, for laboratories where high-volume CPGNB screening may occur, the scalability of PCR (i.e. use of 96 well plates and associated infrastructure) may be more cost and time effective than the manual manipulation required to complete the RCS test The first part of this study involved evaluating five different chromogenic media types to screen for CPGNB. Of the five different chromogenic media evaluated to detect CPGNB, Colorex C3Gr without the ertapenem disk had the highest sensitivity, 95.9%. However, not 11
12 surprisingly, the two ESBL media types (Colorex C3Gr and Brilliance ESBL) without the use of the ertapenem disk lacked specificity allowing growth of most ESBL and AmpC producers. The addition of the ertapenem disk to the two media types designed to detect ESBLs aided to substantially increase the specificity of the media for detection of CPGNB, however, it resulted in a loss of sensitivity. This is the first study to our knowledge that incorporated a carbapenem disk to select for CPGNB off of chromogenic media designed to detect ESBLs Among the three chromogenic media designed for detection of CPGNB, chromid CARBA demonstrated the highest sensitivity and specificity, followed by Colorex KPC and Brilliance CRE. All three media that are designed for detection of CPGNB performed poorly for the detection of OXA-48 producers. A reduced ability to detect OXA-48 producers was also observed by Wilkinson et al in their comparison of four chromogenic media types for the detection of carbapenemase-producing Enterobacteriaceae (15). Some OXA-48 isolates in our study did co-produce other β-lactamases, but these did not appear to consistently play a role in OXA-48 detection on chromogenic media, as was previously described (15). The reduced ability of the chromogenic media evaluated in this study to detect OXA-48 producers is a known limitation of the media. Recently developed media such as SUPERCARBA (9) and chromid OXA- 48 (biomérieux) have been described to have better sensitivity to detect OXA-48 producers (4, 9). Neither of these media were commecerially available in Canada at the time of this study In the second part of the study, a method comparison between the MH test and the RCS was performed on all isolates. Initially, many uninterpretable results with the RCS occurred. At that point, the assay was troubleshot and improvements were made to the modified RCS 12
13 protocol by using one 10 µl calibrated loopful of organism (reduced from two) and a roundbottomed 15 ml tube (instead of a conical 1.5 ml tube) to allow the diatab to dissolve completely. The diatabs did not dissolve completely in the conical bottom test tubes as there was not enough surface area of the diatab in contact with the small volume (150 μl) present in the tube. Also, it was noted after unblinding that if a high inoculum of a carbapenemase negative organism was present in the tubes containing imipenem, these tests would change to a peach color towards the end of incubation. The same uninterpreatble results were reported by Huang et al (5). The modification to a lowered inoculum and use of tubes with increased surface area is unique to this study Upon repeat with the modified RCS protocol a sensitivity of 98% and specificity of 100% was achieved. The RCS failed to identify one OXA-48 producing K. pneumoniae. Previous studies have demonstrated that the RCS like the CarbaNP test does not identify all OXA-48 producers (5, 16). Some intermediate positive results were obtained with the modified RSC and these isolates were tested using the CarbaNP for comparison. The CarbaNP test was easier to interpret than the RCS for intermediate positives; however, the advantage of the RCS is that it is a quality-controlled, commercially available laboratory kit, whereas the CarbaNP test requires 254 preparation of reagents in-house (3, 11, 13). Overall, the vast majority of our tested CPGNB (91.8%) were yellow at 30 minutes, although the current clinical incidence of those enzyme classes that demonstrated an orange positive reaction is unknown. 13
14 This is the first study to date that has compared the RCS to the MH. The RCS proved to be a more sensitive and specific test than the MH, corroborating previous findings that compared the CarbaNP to the MH (3, 11, 13) Lastly, the multiplex PCR for determination of carbapenemase gene class was verified with a sensitivity and specificity of 95.9% and 100%, respectfully. Although the multiplex PCR evaluated had a high sensitive and specificity if used for confirmation, the costs and technical difficulty of the assay was not ideal for routine use, and in our hands will remain an optional test choice for when it is of clinical value to determine the carbapenemase gene class (including for infection and prevention and control investigations) By pairing the top performing screening and confirmatory tests, the preferred workflow was chromid CARBA agar media followed by the Rapid CARB Screen test, yielding a combined sensitivity of 89.8% and a specificity of 100% (Figure 3). The combination of assays was chosen based off of analytical performance characteristics and cost of testing and turnaround time under routine conditions. Even though the combination of Colorex C3Gr with the RCS had a higher sensitivity than chromid CARBA and the RCS, the decreased sensitivity of the Colorex C3Gr media would necessitate substantially more confirmatory testing; in our panel this would equate to twice as many RCS tests, 51 versus 103. On the other hand, the limitation of the chromid CARBA media is the limited detection of OXA-48 producers which is reflected in the sensitivity (89.8%) of the screening algorithm chosen. Our laboratory selected the RCS test for the confirmatory component for cost and time-to-reporting considerations, as the RCS was 14
15 $6.38 less per test and was anticipated to be completed at minimum 3 hours prior to a PCR result Subsequent to the evaluation and verification of this optimized workflow for the detection and confirmation of CPGNB, the chromid CARBA and the RCS test were utilized clinically. A patient was admitted locally after transfer from an international hospital, and was placed immediately on contact precautions in a single-bed room. From a wound specimen, a carbapenem-resistant P. aeruginosa was isolated from the patient using routine culture. The isolate was positive by the RCS test and identified as a VIM producer by the multiplex PCR. A rectal swab was subsequently collected from the patient to screen for CPGNB using the chromid CARBA media and a BA plate with ertapenem disks [(2); the BA plate with ertapenem disks was also selected because the new, verified protocol had not yet had a verification report filed at the time and was not systematically used subsequent to this single collection]. A NDMproducing K. pneumoniae grew on both media types and an OXA-181-producing E. coli grew only on the BA. A ward screen was performed to investigate if these carbapenemase-producing organisms had spread from the isolated patient. As such, 29 rectal swabs were submitted to the clinical microbiology laboratory and plated to chromid CARBA media; 27 (93.1%) had no growth after overnight incubation. Two patient cultures had P. aeruginosa breakthrough these were subbed to BA and tested negative by the RCS the following day (performed off the BA). In addition to the P. aeruginosa, a Gram-positive cocci and a yeast were present on the same chromid CARBA plates. Thus, it appeared in this single investigation that breakthrough is rare on the chromid CARBA media from rectal swabs, and that a Gram stain can be performed to quickly rule out breakthrough growth other than Gram-negative bacilli. 15
16 Limitations of this study include the small number of CPGNB tested within individual carbapenemase classes and the use of pure cultures of stocked isolates for the evaluation as opposed to clinical or mocked rectal swabs. However, strengths to this study include, 1) a diverse subset of CPGNB, 2) the evaluation of multiple chromogenic media and the novel use of a ertapenem disk on ESBL chromogenic media for the selection of CPGNBs, 3) the first study to compare the RCS to the MH, 4) the first study to modify the RCS protocol to improve interpretation of results and 5) a complete workflow approach was tested for the detection to confirmation of CPGNB. 307 Conclusions: Overall, we found that chromid CARBA was the most sensitive and specific chromogenic media evaluated for the detection of CPGNB and with modification to the RCS protocol we were able to more easily interpret the results. By pairing the top-performing screening and confirmatory tests, the preferred workflow was chromid CARBA media followed by the RCS test, yielding a combined sensitivity of 89.8% and a specificity of 100%. The limitation of the selected algorithm is the poor detection of OXA-48 producers Acknowledgements We would like to thank V. Russell and the technologists at each site for their invaluable help with this project and, Oxoid, ThermoFisher, biomérieux, and Alere Canada for providing the chromogenic media, and Inter Medico for providing Rapid CARB Screen kits and International Health Management Associates, Inc (IHMA) and A. Denisuik for providing isolates for this study. 16
17 References 1. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing; 24th Informational Supplement Document M100- S24. Clinical and Laboratory Standards Institute, Wayne, PA. 2. Blackburn, J., C. Tsimiklis, V. Lavergne, J. Pilotte, S. Grenier, A. Gilbert, B. Lefebvre, M. C. Domingo, C. Tremblay, and A. M. Bourgault Carbapenem disks on MacConkey agar in screening methods for detection of carbapenem-resistant Gram-negative rods in stools. J Clin Microbiol 51: Dortet, L., L. Poirel, and P. Nordmann Rapid detection of carbapenemaseproducing Pseudomonas spp. J Clin Microbiol 50: Girlich, D., C. Anglade, G. Zambardi, and P. Nordmann Comparative evaluation of a novel chromogenic medium (chromid OXA-48) for detection of OXA-48 producing Enterobacteriaceae. Diagn Microbiol Infect Dis 77: Huang, T. D., C. Berhin, P. Bogaerts, and Y. Glupczynski Comparative evaluation of two chromogenic tests for the rapid detection of carbapenemase in Enterobacteriaceae and in Pseudomonas aeruginosa isolates. J Clin Microbiol 58: Lolans, K., K. Calvert, S. Won, J. Clark, and M. K. Hayden Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens. J Clin Microbiol 48: Mataseje, L. F., D. A. Boyd, J. Delport, L. Hoang, M. Imperial, B. Lefebvre, M. Kuhn, P. Van Caeseele, B. M. Willey, and M. R. Mulvey Serratia marcescens harbouring 17
18 SME-type class A carbapenemases in Canada and the presence of bla SME on a novel genomic island, SmarGI1-1. J Antimicrob Chemother 69: Mataseje, L. F., E. Bryce, D. Roscoe, D. A. Boyd, J. Embree, D. Gravel, K. Katz, P. Kibsey, M. Kuhn, A. Mounchili, A. Simor, G. Taylor, E. Thomas, N. Turgeon, and M. R. Mulvey Carbapenem-resistant Gram-negative bacilli in Canada : results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother 67: Nordmann, P., D. Girlich, and L. Poirel Detection of carbapenemase producers in Enterobacteriaceae by use of a novel screening medium. J Clin Microbiol 50: Nordmann, P., and L. Poirel The difficult-to-control spread of carbapenemase producers in Enterobacteriaceae worldwide. Clin Microbiol Infect 20: Nordmann, P., L. Poirel, and L. Dortet Rapid detection of carbapenemaseproducing Enterobacteriaceae. Emerg Infect Dis 18: Tijet, N., D. Boyd, S. N. Patel, M. R. Mulvey, and R. G. Melano Evaluation of the Carba NP test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 57: Vasoo, S., S. A. Cunningham, P. C. Kohner, P. J. Simner, J. N. Mandrekar, K. Lolans, M. K. Hayden, and R. Patel Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemaseproducing Gram-negative bacilli. J Clin Microbiol 51: Walsh, T. R Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 36 Suppl 3:S
19 Wilkinson, K. M., T. G. Winstanley, C. Lanyon, S. P. Cummings, M. W. Raza, and J. D. Perry Comparison of four chromogenic culture media for carbapenemaseproducing Enterobacteriaceae. J Clin Microbiol 50: Yusuf, E., S. Van Der Meeren, A. Schallier, and D. Pierard Comparison of the Carba NP test with the Rapid CARB Screen Kit for the detection of carbapenemaseproducing Enterobacteriaceae and Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. [Epub ahead of print]
20 Table 1: Performance of various chromogenic media, multiple confirmation assays and algorithms for the detection and confirmation of carbapenemase-producing Gram-negative bacilli (GNB). Genotype or Phenotype (150) Carbapenemase-producing GNB: N (%) KPC (16) bla KPC- 2, 3,11,12 VIM (12) bla VIM- 1,2,4 a,5 IMP (4) bla IMP- 1,26 NDM (9) bla NDM- 1,2,4,5 OXA (8) bla OXA- 24,48 a SME (1) bla SME Total (49) Carbapenemase negative GNB : N (%) ESBL (12) AmpC (45) Carb S (43) Total (101) Performance for CPGNB Detection (%) Sensitivity Specificity # of confirma -tory tests Cost Time Detection on Chromogenic Media # of tests *List price CAD per plate Brilliance NA ESBL (87.5) (91.6) (100) (100) (50.0) (83.7) (100) (71.1) (41.9) (61.4) Brilliance ESBL with ERT Brilliance CRE ChromID CARBA Colorex C3Gr Colorex C3Gr with ERT Colorex KPC 7 (46.7) 15 (93.8) 16 (100) 16 (100) 16 (100) 4 (33.3) 8 (66.7) 10 (83.3) 12 (100) 10 (83.3) 1 (25.0) 3 (75.0) 4 (100) 4 (100) 4 (100) 6 (66.7) 9 (100) 9 (100) 9 (100) 8 (88.9) 4 (50.0) 4 (50.0) 5 (62.5) 7 (87.5) 6 (75.0) 0 21 (42.9) 0 38 (77.6) 1 44 (100) (89.8) 0 47 (95.9) 1 44 (100) (89.8) 2 (16.7) 3 (25.0) 2 (16.7) 12 (100) 2 (16.7) 2 (4.4) 9 (20.0) 3 (6.7) 41 (91.1) 34 (75.6) 2 (4.7) 1 13 (2.3) (12.9) 0 5 (5.0) 9 62 (20.9) (61.4) 2 (4.7) 6 (5.9) (37.6) NA NA NA NA NA 20 Turn Around Time (TAT) $ hrs $ hrs $ hrs $ hrs $ hrs $ hrs NA (93.8) (83.3) (100) (88.9) (62.5) (83.7) (16.7) (11.1) (2.3) (7.9) $ hrs Confirmation Assays # of tests Cost CAD per assay TAT Modified NA Hodge (87.5) (58.3) (75.0) (66.7) (100) (75.5) (15.6) (6.9) $ hours Rapid CARB NA Screen (100) (83.3) (100) (100) (87.5) (100) (98.0) $ hours Multiplex b 0 c NA $ hours
21 Convention al PCR (100) (100) (100) (100) (87.5) (95.9) Algorithms for the detection and confirmation of carbapenemase producers # of tests Cost per isolate TAT d Brilliance $ ESBL & RCS (87.5) (91.6) (100) (100) (50.0) (83.7) 50 hours Brilliance $ CRE & RCS (93.8) (66.7) (75.0) (100) (50.0) (77.6) 50 hours Chrom ID & RCS (100) (83.3) (100) (100) (50.0) (100) (89.8) $ hours Colorex C3Gr & RCS (100) (100) (100) (100) (87.5) (95.9) $ hours Colorex KPC & RCS (93.8) (83.3) (100) (88.9) (62.5) (83.7) $ hours Colorex PCR C3Gr & (100) (100) (100) (100) (75.0) (91.8) Multiplex $ hours chromid PCR CARBA & (100) (83.3) (100) (100) (50.0) (100) (89.8) Multiplex $ hours 1 2 a One Enterobacter cloacae isolate possessed both VIM-4 and OXA-48 3 b One OXA-24 producer was not identified by the multiplex conventional PCR as it is specific for bla OXA-48 (6). 4 c bla SME is not a target in the multiplex PCR. However, a simplex PCR for bla SME was performed and was positive for the isolate (70). 5 RCS: Rapid CARB Screen, GNB: Gram-negative bacilli, CPGNB: Carbapenemase-producing Gram-negative bacilli, mins: minutes, hrs: 6 hours. NA: Not applicable. 7 d Factoring in the likelihood of the need for a pure culture to initiate any confirmatory testing 8 21
22 Figure 1: Troubleshooting the Rapid Carb Screen test with the use of different tubes and increasing inoculum. A 1a 1b 2a 2b 3b 3a B 17 1a 1b 2a 2b 3a 3b C 1a 1b 2a 2b 3b 3a Rapid CARB Screen comparing the test in A) round bottom 15 ml tubes, B) Cryovials and C) test tubes using a AmpC-producing Enterobacter cloacae (should yield a negative result by RCS). 1 a) Tube with imipenem 1b) Tube without imipenem; using one calibrated 10 μl loop of organism. 2a) Tube with imipenem, 2b) Tube without imipenem; using two calibrated 10 μl loops of organism. 3a) Tube with imipenem, 3b) Tube without imipenm; using three calibrated 22
23 μl loops of organism. Of note, as the inoculum increases tube with imipenem (Tube A) in the Cryovials and Test tubes demonstrate that it turns a peach color in comparison to the tube without Imipenem (Tube B). In addition, the color change in the test tubes (C) is not apparent as the diatabs were not able to properly dissolve and result in uninterpretatble results especially with increased inoculum. The round bottom 15 ml tubes A) demonstrated the most easy to interpret results
24 Figure 2: Comparison of the Rapid CARB Screen to the CarbaNP for a SME producing Serratia marcsens at two hours of incubation (intermediate positive; orange hue). A 1a 1b 2a 2b 3a 3b 41 B 1a 1b 2a 2b 3a 3b A. Rapid CARB Screen Results using round bottom 15 ml tubes and one full 10 μl calibrated loop of organism. B. CarbaNP Assay using 1.5ml conical test tubes and one full 10 μl calibrated loop of organism. 1. Positive Control: K. pneumoniae ATCC BAA1705; 2. Negative Control: K. pneumoniae ATCC BAA1706 and 3. SME-producing Serratia marcenscens. Tubes a) without imipenem and tubes b) with imipenem. In section A, note the dissolved diatabs settling at the bottom of the tubes
25 Figure 3: The chosen workflow for the detection and confirmation of carbapenemase-producing Gram-negative bacilli using chromid CARBA media for the detection and the Rapid CARB Screen for confirmation. After hours of incubation, examine the chromid CARBA No Growth Issue final report with NOCP No GNB No further workup Growth perform Gram stain to confirm Gram-negative bacilli GNB Note: color of growth is indicative of: Pink-Burgundy: E. coli Bluish green-gray: Klebsiella Enterobacter Serratia Citrobacter group Subculture to a BA to perform the Rapid Carb Screen the following day. Initiate ID of GNB if sufficient growth is present on chromid CARBA, or ID from BA the following day Any isolate is RCS All isolates are RCS 71 NOCP CARBP Report ID of RCS positive isolates, and add CARBP comment Notify IP&C and IDS No carbapenemase-producing Gram-negative bacteria isolated. No ID are reported, and add NOCP comment This isolate contains a carbapenemase and demonstrates reduced susceptibility to carbapenems. Consultation with the Infectious Disease Service is recommended. Follow the Infection Prevention & Control guidelines for Antibiotic Resistant Organisms (ARO) and/or contact Infection Prevention and Control practitioner. 25
26 GNB: Gram-negative bacilli, IP&C: Infection Prevention and Control, ID: Infectious Disease Service 75 26
A Comparison of Four Chromogenic Culture Media for. Carbapenemase-producing Enterobacteriaceae.
JCM Accepts, published online ahead of print on 3 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.01613-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 A Comparison of Four
More informationCRE Laboratory Testing and CRE Lab Testing Recommendations in-depth recommendations on CRE laboratory detection
December 2014 Dear Laboratory Director, The Illinois Department of Public Health (IDPH) amended the Control of Communicable Diseases Code (77 Ill. Adm. Code 690) to require reporting of Carbapenem-Resistant
More informationBD BBL CHROMagar CPE
INSTRUCTIONS FOR USE READY-TO-USE PLATED MEDIA BD BBL CHROMagar CPE PA- 257681.02 Rev. January 2017 INTENDED USE BD BBL CHROMagar CPE is a selective chromogenic screening medium for the detection of carbapenemase
More informationLauren A. Darling1#, Ann M. Evans1, Kathleen A. Stellrecht1,2, Seela M. Nattanmai1,
JCM Accepted Manuscript Posted Online 20 September 2017 J. Clin. Microbiol. doi:10.1128/jcm.01185-17 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 JCM Letter to the Editor Submission
More informationCombatting AMR: diagnostics
Combatting AMR: diagnostics Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright Gonorrhoea: a paradigm for better diagnostics International
More informationLaboratory Detection of Carbapenemase-producers
Laboratory Detection of Carbapenemase-producers John D. Perry Clinical Scientist Freeman Hospital Newcastle upon Tyne Carbapenemase-producing Gram-negative Microorganisms. Where are we now? Challenges
More informationCarbapenem-resistant Enterobacteriaceae (CRE): Surveillance and Response. David Selvage, MHS, PA-C New Mexico Department of Health March 15, 2016
Carbapenem-resistant Enterobacteriaceae (CRE): Surveillance and Response David Selvage, MHS, PA-C New Mexico Department of Health March 15, 2016 What are Carbapenem-resistant Enterobacteriaceae (CRE)?
More informationNEXT STEP TO STOP THE SPREAD OF ANTIMICROBIAL RESISTANCE. Patricia Ruiz Garbajosa Servicio de Microbiología Hospital Universitario Ramón y Cajal
NEXT STEP TO STOP THE SPREAD OF ANTIMICROBIAL RESISTANCE Patricia Ruiz Garbajosa Servicio de Microbiología Hospital Universitario Ramón y Cajal ANTIMICROBIAL RESISTANCE AND HEALTHCARE-ASSOCIATED INFECTION
More informationUse of Molecular Assays for Resistance Detection
Use of Molecular Assays for Resistance Detection Antimicrobial resistance and susceptibility are complex, and current in vitro methods have been developed to predict a microorganism s response to antibacterial
More informationScreening for Resistant Organisms and Infection Control
Screening for Resistant Organisms and Infection Control Dr Sonal Saxena Professor Department of Microbiology Lady Hardinge Medical College New Delhi 1 MDRO The proportion of K. pneumoniae and E. coli with
More informationThe Laboratory Diagnosis of Enterobacteriaceae that produce Carbapenemases. and Johann DD Pitout 1-3
JCM Accepts, published online ahead of print on 19 September 2012 J. Clin. Microbiol. doi:10.1128/jcm.02117-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 The Laboratory Diagnosis
More informationCARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE) LABORATORY CAPACITY SURVEY. Summary Data Report
CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE) LABORATORY CAPACITY SURVEY June 2015 Introduction The rise of antimicrobial-resistant organisms represents a serious threat to public health. In 2013, CDC
More informationTitle: Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR
JCM Accepts, published online ahead of print on 11 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.00991-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11
More informationGuidelines for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel
Guidelines for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes
More informationProtocols for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel
Protocols for Laboratory Verification of Performance of the FilmArray Blood Culture Identification (BCID) Panel Purpose The Clinical Laboratory Improvement Amendments (CLIA), passed in 1988, establishes
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Blood Culture Identification (BCID) Panel
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Blood Culture Identification (BCID) Panel A Laboratory Protocol for Use with Live s Purpose The Clinical Laboratory Improvement
More informationDATE OF ISSUE: 21/05/2013. ROSCO Diagnostica A/S, Taastrupgaardsvej 30, DK-2630 Taastrup, Denmark.
Insert for KPC/MBL in P. aeruginosa/acinetobacter Confirm Kit (98020) REVISION: DBV00 DATE OF ISSUE: 21/05/2013 LANGUAGE: English KPC/MBL in P. aeruginosa/acinetobacter Confirm Kit FOR IN VITRO DIAGNOSTIC
More informationEducational Workshops 2016
Educational Workshops 2016 Case One: Outbreak of CPE We are grateful to Suzy Fitzgerald, Consultant Microbiologist, St Vincent s University Hospital, Dublin for composing this case. 2011 Spring 2011 Sporadic
More informationTen Minute, Reagent-Free identification of Bacteria Containing Resistance Genes Using a Rapid Intrinsic Fluorescence Method
548 Ten Minute, Reagent-Free identification of Bacteria Containing Resistance Genes Using a Rapid Intrinsic Fluorescence Method R. Rozen-Sadowsky 1, A. Shinderman 1, D. Gohman 1, D. Shimonov 1, Y. Gluckman
More informationReceived 23 December 2010/Returned for modification 11 January 2011/Accepted 7 February 2011
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1608 1613 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.02607-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Evaluation
More informationAccurate and Timely Identification of Genes Conferring Resistance to Carbapenems Serves as an Important Tool for Infection Control Measures
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 05 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.705.296
More informationAbstract. Introduction
ORIGINAL ARTICLE BACTERIOLOGY A sensitive and specific phenotypic assay for detection of metallo-blactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic
More informationThe ARLN: CRE and CRPA Testing & Troubleshooting Lab Results 5/3/2017
The ARLN: CRE and CRPA Testing & Troubleshooting Lab Results 5/3/2017 After the program, send questions to ARLN@cdc.gov. Speakers Maria Karlsson, PhD, Clinical and Environmental Microbiology Branch, Division
More informationInfection Control Forum HA Fact Sheet on Carbapenem resistant Enterobacteriaceae (CRE)
Infection Control Forum HA Fact Sheet on Carbapenem resistant Enterobacteriaceae (CRE) 9th December 2010 Lecture Theatre, G/F Centre for Health Protection Gram positive cocci Staphylococcus aureus Streptococcus
More informationPERANAN MIKROBIOLOGI DALAM DIAGNOSIS PENYAKIT INFEKSI. dr. Agus Eka Darwinata, Ph.D.
PERANAN MIKROBIOLOGI DALAM DIAGNOSIS PENYAKIT INFEKSI dr. Agus Eka Darwinata, Ph.D. CLINICAL MICROBIOLOGY Clinical microbiology is the discipline of detection, characterization, and quantification of
More informationA Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1
A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease
More informationCRE is not the first organism we ve had that has become resistant to antibiotics, so why is it so important? CRE resistance is complex because it can
1 Enterobacteriaceae are a large family of bacteria that are a normal part of a person's digestive system (2). Examples include Escherichia coli and species of the genera Klebsiella, Enterobacter, Serratia,
More informationA Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae
A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease
More informationTable of Contents. A Culture of Service
102714tr Table of Contents 1 BlueEcoli 2 Candida 3 CRE 4 ECC 5 HurBi 6 ESBL 7 Listeria 8 MRSA 9 O157 10 Sakazakii 11 Salmonella 12 SS 13 Staph aureus 14 UTI 15 Vibrio Headquarters A Culture of Service
More informationEvaluation of the Carba NP Test for the Detection of Carbapenemase Activity in Bacteroides Species
Polish Journal of Microbiology 2018, Vol. 67, No 1, 97 101 SHORT COMMUNICATION Evaluation of the Carba NP Test for the Detection of Carbapenemase Activity in Bacteroides Species ISIN AKYAR 1, 2, *, MELTEM
More informationCME/SAM. Clinical Laboratory Detection of AmpC β-lactamase Does It Affect Patient Outcome?
Microbiology and Infectious Disease / Laboratory Detection of AmpC β-lactamase Clinical Laboratory Detection of AmpC β-lactamase Does It Affect Patient Outcome? Kenneth H. Rand, MD, 1 Bradley Turner, MD,
More informationM. Ben-David 1, O. Hammer 1, A.Shinderman 1, Y. Gluckman- Yavo 1, M. Fridman 1, D. Gohman 1, G. Ingber 1 and E. Zahavy 2
437 Fast Antibiotic Susceptibility Testing Utilizing a Unique Spectral Intensity Ratio Analysis via Single Fluorescence Membrane Dye Staining and Flow Cytometry M. Ben-David 1, O. Hammer 1, A.Shinderman
More informationEzy MIC Strip FEATURES AND ADVANTAGES
Imipenem with & without EDTA Ezy MIC Strips (IPM+EDTA/IPM) (Imipenem + EDTA: 1-64 mcg/ml) (Imipenem : 4-256 mcg/ml) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM078 Not for Medicinal
More informationEvaluation of The BIOMIC V3 Microbiology System for Identification of Selected Species on BBL CHROMagar Orientation and CHROMagar MRSA ACCEPTED
JCM Accepts, published online ahead of print on 13 August 2008 J. Clin. Microbiol. doi:10.1128/jcm.02460-07 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationMultidrug-Resistant Organisms: Where Are We with Detection and Reporting in 2015?
Analysis. Answers. Action. www.aphl.org Multidrug-Resistant Organisms: Where Are We with Detection and Reporting in 2015? Audrey N. Schuetz, MD, MPH 1 Faculty Disclosure The Association of Public Health
More informationWELCOME. to the CDS WORKSHOP
WELCOME to the CDS WORKSHOP Sydney 2010 Excel Spreadsheet for Registration Recent Additions to the CDS Doripenem 10mg disc A carbapenem claimed to be more active against Pseudomonas than Meropenem Daptomycin:
More informationUser manual. Check-Direct CPE for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae
User manual Check-Direct CPE for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae Version 1.3 Date of issue: 24.01.2014 18-0081 48 081-04 INTENDED USE...2 INTRODUCTION
More informationCuring antibiotic resistance in vivo. Muhammad Kamruzzaman
Curing antibiotic resistance in vivo Muhammad Kamruzzaman Occurrence of resistance -Some bacteria are naturally resistant to certain antibiotics -Gene mutation -Horizontal transfer of antibiotic resistance
More informationCheck-Direct CPE Screen for BD MAX For detection and differentiation of carbapenemase genes from Enterobacteriaceae in rectal swabs
User manual Check-Direct CPE Screen for BD MAX For detection and differentiation of carbapenemase genes from Enterobacteriaceae in rectal swabs Version 1.4 Date of issue: 11.08.2016 18-0051 24 Contents
More informationF or many years, the isolation of urinary pathogens has
608 ORIGINAL ARTICLE A comparison of the performance of commercially available chromogenic agars for the isolation and presumptive identification of organisms from urine D Fallon, G Ackland, N Andrews,
More informationNew Efforts in Combating Antibiotic Resistance The Antibiotic Resistance Laboratory Network
New Efforts in Combating Antibiotic Resistance The Antibiotic Resistance Laboratory Network Paula Snippes Vagnone MT(ASCP) July 11, 2017 MN Laboratory System Webinar Series Objectives Describe the ARLN,
More informationAntibiotic Susceptibility Testing (ABST/AST)
Antibiotic Susceptibility Testing (ABST/AST) Goal Offer guidance to physicians in selecting effective antibacterial therapy for a pathogen in a specific body site. Performed on bacteria isolated from clinical
More informationEnvironmental Surveillance FIDSSA Dr Ben Prinsloo Medical Microbiologist
Environmental Surveillance FIDSSA 2015 Dr Ben Prinsloo Medical Microbiologist The Scientist A scientist, in a broad sense, is a person engaging in a systematic activity to acquire knowledge We require
More informationCurriculum Vitae. Abbas Maleki, Ph.D. Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran
Curriculum Vitae Abbas Maleki, Ph.D Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran E-mail: abbasmaleki_ilam@yahoo.com maleki-a@medilam.ac.ir Tel: +989187419401 Personal
More informationChromogenic Culture Media
Color is my day-long obsession, joy, and torment. - Claude Monet Chromogenic Culture Media A Culture of Service Contents BluEcoli CRE Candida ECC E. coli O157 ESBL HUrBi Listeria MRSA SS (Salmonella Shigella)
More informationPhenotypic and Genotypic Detection of Metallo-Beta-Lactamases among Imipenem Resistant Gram Negative Isolates
Phenotypic and Genotypic Detection of Metallo-Beta-Lactamases among Imipenem Resistant Gram Negative Isolates Mohammad Mohammadzadeh 1*, Mahnaz Tavakoli 1, Abolfazl Mohebi 2, Samad Aghayi 2 1 Department
More informationESBLs and KPCs: Impact of Revised CLSI Breakpoints on testing and Reporting Algorithms
ESBLs and KPCs: Impact of Revised CLSI Breakpoints on testing and Reporting Algorithms Stephen G. Jenkins, Ph.D. Director, Clinical Microbiology Laboratories New York/Presbyterian Hospital Weill Cornell
More informationRapid Aminoglycoside NP test for rapid detection of multiple. aminoglycoside resistance in Enterobacteriaceae
JCM Accepted Manuscript Posted Online 18 January 2017 J. Clin. Microbiol. doi:10.1128/jcm.02107-16 Copyright 2017 American Society for Microbiology. All Rights Reserved. 1 2 Rapid Aminoglycoside NP test
More informationJOHN DEMPSEY HOSPITAL Farmington, Connecticut ANTIBIOTIC SUSCEPTIBILITY PROFILES for INPATIENT Bacterial Isolates
JOHN DEMPSEY HOSPITAL Farmington, Connecticut 2017 ANTIBIOTIC SUSCEPTIBILITY PROFILES for INPATIENT Bacterial Isolates **GROUPED BY CULTURE SOURCES** (data from 1/1/17 1/1/18) Prepared by: UCHC/JDH Antimicrobial
More informationProtocols for Laboratory Verification of Performance of the BioFire FilmArray Blood Culture Identification (BCID) Panel
Protocols for Laboratory Verification of Performance of the BioFire FilmArray Blood Culture Identification (BCID) Panel Laboratory Protocols for Use with Microbiologics Helix Elite Molecular Standards
More informationCharacterization of the modified Hodge testpositive isolates of Enterobacteriaceae in Taiwan
Journal of Microbiology, Immunology and Infection (2013) 46, 35e40 Available online at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE Characterization of the modified Hodge testpositive
More informationDifficult or Tricky Antibiotic Resistance Phenotypes to Recognize. Tan Thean Yen
Difficult or Tricky Antibiotic Resistance Phenotypes to Recognize Tan Thean Yen Contents Gram-positive Staphylococcus aureus with penicillinase production Vancomycin resistant Enterococci (VRE) Staphylococcus
More informationRapid Diagnostic Tests for Antimicrobial Resistance: Comparability of Results and Interpretation of Data
Rapid Diagnostic Tests for Antimicrobial Resistance: Comparability of Results and Interpretation of Data Christopher Teale, Animal and Plant Health Agency, UK. 12 th OIE One-Day Seminar, in association
More informationReceived 16 September 2005/Accepted 20 September 2005
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2005, p. 5945 5949 Vol. 43, No. 12 0095-1137/05/$08.00 0 doi:10.1128/jcm.43.12.5945 5949.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More informationEmergence and persistence of integron structures harbouring VIM genes in the Children s Memorial Health Institute, Warsaw, Poland,
Journal of Antimicrobial Chemotherapy (2009) 63, 269 273 doi:10.1093/jac/dkn512 Advance Access publication 18 December 2008 Emergence and persistence of integron structures harbouring VIM genes in the
More informationLooking to the Future: How Automation will Grow the Value of Microbiology
Looking to the Future: How Automation will Grow the Value of Microbiology Nathan A Ledeboer Associate Professor of Pathology Medical College of Wisconsin Medical Director, Microbiology and Molecular Pathology
More informationTeicoplanin has not yet been evaluated, but we expect it will perform like vancomycin.
Detection of VISA, GISA, hvisa, VRE, Staphylococci Daptomycin Resistant, and Acinetobacter/Pseudomonas Colistin Resistant, using the Neo Sensitabs prediffusion method. S. aureus CB 182, Susceptible strain.
More informationPrevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea
Original Article Clinical Microbiology Ann Lab Med 6;6:9- http://dx.doi.org/.4/alm.6.6.6.9 ISSN 4-86 eissn 4-84 Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From
More informationHardyCHROM HUrBi Biplate
HardyCHROM HUrBi Biplate Cat. no. J100 HUrBi, 15x100mm Biplate, 10ml/10ml 10 plates/bag INTENDED USE HardyCHROM HUrBi Biplate is a selective chromogenic medium recommended for the cultivation, differentiation
More informationMolecular susceptibility testing
Molecular susceptibility testing Dr Andrew Ginn Supervising Scientist Antimicrobial Resistance Reference Laboratory ICPMR, Westmead Hospital Resistance genes Gram negatives Transmissible; e.g. ESBLs, MBLs,
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.393, ISSN: , Volume 2, Issue 8, September 2014
EVALUATION OF CHROMAGAR-CTX FOR THE DETECTION OF CTX-M-ESBL- PRODUCING GRAM NEGATIVE BACTERIAL ISOLATES RASHA H. ELSHERIF* LAMIAA A. MADKOUR** REHAM A. DWEDAR*** *Clinical Pathology Department, Faculty
More informationJean-Winoc Decousser a,b, Laurent Poirel c,d,e and Patrice Nordmann c,d,e,f. 1. Introduction REVIEW General statements
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017 http://dx.doi.org/10.1080/14737159.2017.1289087 REVIEW Recent advances in biochemical and molecular diagnostics for the rapid detection of antibiotic-resistant
More informationUser manual. Check-Direct CPE. Screen for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae
User manual Check-Direct CPE Screen for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae Version 1.0 Date of issue: 09.09.2014 18-0051 24 51-01 EU: U.S.: For Research
More informationDetection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures in non-hospitalized patients
Sayed et al. Journal of Analytical Science and Technology (2017) 8:4 DOI 10.1186/s40543-017-0114-0 Journal of Analytical Science and Technology RESEARCH ARTICLE Open Access Detection of carbapenemase-producing
More informationCDC Antibiotic Resistance Laboratory Network- Southeast Region. Nailah Smith, DVM, MPH, Epidemiologist
CDC Antibiotic Resistance Laboratory Network- Southeast Region Nailah Smith, DVM, MPH, Epidemiologist Overview ARLN Introduction Southeast Regional Laboratory Overview ARLN Alert Values Isolate flow CRE
More informationVanABC plus. GENSPEED VanABC plus. Molecular multiplex assay for maximum information.
VanABC plus GENSPEED VanABC plus Molecular multiplex assay for maximum information www.genspeed-biotech.com Vancomycin Resistance? VanABC plus for all relevant targets GENSPEED VanABC plus Molecular multiplex
More informationStandard Operating Procedure
Subject Vitek 2 Compact Identification and Susceptibility Testing Index Number Lab-1512 Section Laboratory Subsection Regional Clinic / Affiliate Hospital Laboratories Category Departmental Contact Sanders,
More informationSUMMARY. Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M,
SUMMARY Key words: antibioticresistance, Enterobacteriaceae, ESBL, CTX-M, The doctoral thesis entitled Prevalence of Enterobacteriaceae producing extendedspectrum beta-lactamases (ESBL) isolated from broilers
More informationTest Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces
Test Method for the Continuous Reduction of Bacterial Contamination on Copper Alloy Surfaces Test Organisms: Staphylococcus aureus (ATCC 6538) Enterobacter aerogenes (ATCC 13048) Pseudomonas aeruginosa
More informationResistance, Yonsei University College of Medicine, Seoul, Korea; and 2 Department of
AAC Accepts, published online ahead of print on March 0 Antimicrob. Agents Chemother. doi:./aac.0- Copyright 0, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationon January 30, 2019 by guest
JCM Accepted Manuscript Posted Online 5 January 2018 J. Clin. Microbiol. doi:10.1128/jcm.01678-17 Copyright 2018 American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13 14
More information1. Procedure for Antibiotic susceptibility test by disc diffusion analysis
Nanoparticles Functionalized with Ampicillin Destroy Multiple Antibiotic Resistant Isolates of Pseudomonas aeruginosa, Enterobacter aerogenes and Methicillin Resistant Staphylococcus aureus Ashley Brown
More informationGENOTYPIC CHARACTERISATION OF CARBAPENEM RESISTANT ESCHERICHIA COLI
GENOTYPIC CHARACTERISATION OF CARBAPENEM RESISTANT ESCHERICHIA COLI ISOLATES FROM BLOOD STREAM INFECTION AND FALLACIES ASSOCIATED WITH MODIFIED HODGE TEST TO DETECT PRODUCTION OF CARBAPENEMASES Priyadarshini
More informationIMPLEMENTATION OF EUCAST BREAKPOINTS
IMPLEMENTATION OF EUCAST BREAKPOINTS BELGIAN /GDL COUNTDOWN UNTIL 1ST JANUARY 2010 : 64 DAYS Pierrette Melin, CHU of Liege Coordinator of the SBIMC-BVIKM/EUCAST microbiology working party 1 Introduction
More informationEvaluation of Brilliance ESBL Agar, a Novel Chromogenic Medium for Detection of Extended-Spectrum-Beta- Lactamase-Producing Enterobacteriaceae
JOURNAL OF CLINICAL MICROBIOLOGY, June 2010, p. 2091 2096 Vol. 48, No. 6 0095-1137/10/$12.00 doi:10.1128/jcm.02342-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Evaluation
More informationM. Ben-David 1, O. Hammer 1, A.Scinderman 1, Y. Gluckman-Yavo 1, M. Fridman 1, D. Gohman 1, G. Ingber 1 and E. Zahavy 2
441 Rapid Gram Negative Antimicrobial Susceptibility Testing Directly from Positive Blood Culture based on a Unique Spectral Intensity Ratio Analysis via Single Fluorescence Membrane Dye Staining and Flow
More informationUrinary tract infections (UTIs) are the second most common infections, only after respiratory tract tinfections.
Detection of fu Uropathogens by Using Chromogenic Mdi Media Farzaneh Azizmohseni, Director of Persian Type Culture Collection ((PTCC) Introduction Urinary tract infections (UTIs) are the second most common
More informationBeta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of betalactamase inhibiter combinations
Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of betalactamase inhibiter combinations Dr Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology,
More informationBiofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement
Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms
More informationCORPORATE PRESENTATION
CORPORATE PRESENTATION March 2018 1 Forward Looking Statement This presentation includes statements relating to the company's Acuitas MDRO and Acuitas Lighthouse clinical laboratory services, FDA cleared
More informationVerification of Disk Diffusion Tests
Verification of Disk Diffusion Tests Objectives 1. Describe disk diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification of
More informationLABORATORY PROTOCOL. Isolation of ESBL-, AmpC- and carbapenemase-producing E. coli from caecal samples
LABORATORY PROTOCOL Isolation of ESBL-, AmpC- and carbapenemase-producing E. coli from caecal samples November 2017 Version 5 Henrik Hasman, Yvonne Agersø, Rene Hendriksen, Lina M. Cavaco (DTU Food) and
More informationMethods of Measuring Zones of Inhibition with the Bauer- Kirby Disk Susceptibility Test
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1979, p. 885-889 0095-1137/79/12-0885/05$02.00/0 Vol. 10, No. 6 Methods of Measuring Zones of Inhibition with the Bauer- Kirby Disk Susceptibility Test ARTHUR L.
More informationWP8 Branka Bedenic, University Hospital Zagreb, Croatia Valentino D Onofrio, Jessa hospital and Hasselt University, Belgium
WP8 Branka Bedenic, University Hospital Zagreb, Croatia Valentino D Onofrio, Jessa hospital and Hasselt University, Belgium Inge Gyssens, Jessa hospital and Hasselt University and Radboud University Medical
More informationINTRODUCTION. Original Article
Chattagram Maa-O-Shishu Hospital Medical College Journal Original Article Comparison Between Phenotypic Confirmatory Test & Double Disc Synergy Test in Detection of Extended Spectrum β-lactamases Producers
More informationDisruptive Technology to Guide Precision Antibiotic Therapy
Disruptive Technology to Guide Precision Antibiotic Therapy Company Presentation, October 2018 Forward Looking Statement This presentation includes statements relating to the company's Acuitas AMR Gene
More informationOriginal article DOI: Journal of International Medicine and Dentistry 2016; 3(1): 34-41
Original article DOI: http://dx.doi.org/10.18320/jimd/201603.0134 JOURNAL OF INTERNATIONAL MEDICINE AND DENTISTRY To search..to know...to share p-issn: 2454-8847 e-issn: 2350-045X Comparative analysis
More informationDetection of carbapenemase producers in clinical laboratories
crossmark Triton Hodge Test: Improved Protocol for Modified Hodge Test for Enhanced Detection of NDM and Other Carbapenemase Producers Fernando Pasteran, a Lisandro J. Gonzalez, b Ezequiel Albornoz, a
More informationAntimicrobial Susceptibility Testing Disk Diffusion
Antimicrobial Susceptibility Testing Disk Diffusion Babak Valizadeh,DCLS Babak_Valizadeh@hotmail.com 1390 / 09 / 10 2011.12.01 1 2 3 CLSI - M02-A10 / 2009 4 CLSI M100-S21 / 2011 Antimicrobial Susceptibility
More informationThe biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush
International Newsletter n 4 December 2003 Through the IDENTIFYING RESISTANCE Newsletter, biomérieux s ambition is to contribute to the awareness and progress in the field of resistance to antibiotics.
More informationMechanism for carbapenem resistance of clinical Enterobacteriaceae isolates
EXPERIMENTAL AND THERAPEUTIC MEDICINE 15: 1143-1149, 2018 Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates YAFEI YE, LIJUAN XU, YANPING HAN, ZHE CHEN, CAILIN LIU and LIANG MING
More informationOriginal Research article Prevalence of Metallo-betalactamases (MBL) producing Pseudomonas aeruginosa in a Tertiary care Hospital.
Original Research article Prevalence of Metallo-betalactamases (MBL) producing Pseudomonas aeruginosa in a Tertiary care Hospital. Dr Anil Rajput*, Dr Bhavin Prajapati **, Dr.Bimal Chauhan***, Dr Atit
More informationNational Pilot Study of Carbapenemase-producing Carbapenem Resistant Enterobacteriaceae (CRE) in Critical Care Units in the Republic of Ireland
National Pilot Study of Carbapenemase-producing Carbapenem Resistant Enterobacteriaceae (CRE) in Critical Care Units in the Republic of Ireland Study Protocol Version 1.4 June 2011 Table of Contents Table
More informationIDEXX is an ISO certified facility. Gil Dichter World Wide Technical Support Manager
USEPA ATP Process for Approval of Colilert-18 and Quanti-Tray for the Detection of Fecal Coliforms in Waste Water; What is a Number: Comparison of MPN and CFU Gil Dichter World Wide Technical Support Manager
More informationANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED
ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED Romney Humphries, Ph.D., DABMM Section Chief, Clinical Microbiology University of California Los Angeles Lost Angeles, CA Susan E. Sharp, Ph.D., DABMM, FAAM
More informationTest Method for Efficacy of Copper Alloy Surfaces as a Sanitizer
Test Method for Efficacy of Copper Alloy Surfaces as a Sanitizer Test Organisms: Staphylococcus aureus (ATCC 6538) Enterobacter aerogenes (ATCC 13048) Pseudomonas aeruginosa (ATCC 15442) Methicillin Resistant
More informationAre There Non-Carbapenem β-lactam Options for Treating ESBL Infections?
CIDEIM Are There Non-Carbapenem β-lactam Options for Treating ESBL Infections? Pranita D. Tamma, M.D., M.H.S. Assistant Professor, Pediatrics Director, Pediatric Antimicrobial Stewardship Program CIDEIM
More informationCurrent trends in culture-based and molecular detection of ESBL- harboring and carbapenem-resistant Enterobacteriaceae
JCM Accepts, published online ahead of print on 18 January 2012 J. Clin. Microbiol. doi:10.1128/jcm.06852-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Current trends in
More informationNovel Approaches to Further Antibacterial Drug Development: New Approaches to the Clinical Development Program
Novel Approaches to Further Antibacterial Drug Development: New Approaches to the Clinical Development Program An industry view John H. Rex, Infection Clinical Vice President AstraZeneca Pharmaceuticals
More informationIQCP for Disk Diffusion Antimicrobial Susceptibility Testing (AST)
IQCP for Disk Diffusion Antimicrobial Susceptibility Testing (AST) Test System: Disk Diffusion Antimicrobial Susceptibility Testing (Kirby Bauer) / Twelve Disk Diffusion Test using BBL Disks Facility:
More information